United States
Germany
Japan
United Kingdom
China
Carrier-free (BSA/glycerol-free) SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI3E7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Primary Antibodies
Carrier-free (BSA/glycerol-free) SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI1H6
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Carrier-free (BSA/glycerol-free) SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI5A7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 N protein mouse monoclonal antibody, clone OTI4B9
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 N Protein Mouse Monoclonal Antibody, Clone OTI3E1
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 N protein mouse monoclonal antibody, clone OTI4F8
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI3H6
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI4C6
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 N Protein Mouse Monoclonal Antibody, Clone OTI8G10
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 N protein mouse monoclonal antibody, clone OTI6C3
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI5A7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI3A2
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI1H6
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI13E8
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI2H7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
